Genome Medical
PrivateLast Round
Series D
Sep 1, 2024
Est. Valuation
$39M
Total Funding Raised
$195.34M
Company Overview
Genome Medical is a digital health company that provides telehealth-enabled genetic counseling and genomic medicine services to individuals, healthcare providers, and health systems.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Precision Medicine, Clinical Trials, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genome Medical Comparables
Compare Genome Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InformedDNA | 85% | |
| Metis Genetics | 82% | |
| DNAvisit | 81% |
Genome Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 1, 2024 | ||||
| Series C | Aug 30, 2021 | ||||
| Series B Extension | Jul 1, 2020 | ||||
| Series B | Jun 11, 2019 | ||||
| Series A Extension | Jan 5, 2018 | ||||
Series A | May 25, 2017 |
Genome Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series C |
| Perceptive Advisors | Series C, Series B Extension, Series B |
| Kaiser Permanente Ventures | Series C, Series B Extension, Series B, Series A Extension |
| Manatt Ventures | Series B, Series B Extension |
| Avestria Ventures | Series C, Series B Extension |
| Dreamers VC | Series C, Series B Extension |
| Amgen Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2025
Recognized as one of the Top 50 in Digital Health.
- Jan 17, 2025
Partnered with Nest Genomics to expand genetic services access.
Recent news
Latest coverage and updates
- launchesJul 7, 2026
Genome Medical, Inc. launched clinical trial recruitment services on Jul 8th '26.
Genome Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genome Medical's valuation, stock price, and market status.
Is Genome Medical a public or private company?
Genome Medical is a private company.
What is the current stock price of Genome Medical?
Genome Medical is a private company with no public stock price. No recent secondary market data is available.
How much is Genome Medical worth (valuation)?
Genome Medical's valuation is estimated at $39.0M based on funding round data.
Can I buy Genome Medical stock?
Genome Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genome Medical's last funding round?
Genome Medical's most recent funding round was Series D on January 5, 2018.
Who are the main investors in Genome Medical?
Key investors in Genome Medical include Canaan Partners, Casdin Capital, Echo Health Ventures, GE Ventures.
Will Genome Medical IPO soon?
No public IPO plans have been announced for Genome Medical.
How can I track Genome Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genome Medical's secondary market activity and sign up for updates.